ImmuCell Corporation Deferred Federal Income Tax Expense (Benefit)
ImmuCell Corporation (ICCC) reported Deferred Federal Income Tax Expense (Benefit) of -$220.76 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-03-30
- ImmuCell Corporation deferred federal income tax expense (benefit) for fiscal 2025 was -$220.76K.
- ImmuCell Corporation deferred federal income tax expense (benefit) for fiscal 2024 was -$500.93K, a 142.47% decline from fiscal 2023.
- ImmuCell Corporation deferred federal income tax expense (benefit) for fiscal 2023 was $1.18M, a 104.49% increase from fiscal 2022.
- ImmuCell Corporation deferred federal income tax expense (benefit) for fiscal 2022 was $576.78K.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month | Deferred Federal Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$220.76K 10-K · filed 2026-03-30 | |
| 2024-12-31 | -$500.93K 10-K · filed 2026-03-30 | $500.93K 10-K · filed 2025-03-28 |
| 2023-12-31 | $1.18M 10-K · filed 2025-03-28 | |
| 2022-12-31 | $576.78K 10-K · filed 2024-04-01 | -$576.78K 10-K · filed 2023-03-29 |
| 2021-12-31 | -$63.10K 10-K · filed 2023-03-29 | $63.10K 10-K · filed 2022-03-30 |
| 2020-12-31 | $418.30K 10-K · filed 2022-03-30 | -$418.30K 10-K · filed 2021-03-30 |
| 2019-12-31 | -$240.46K 10-K · filed 2021-03-30 | |
| 2018-12-31 | -$274.50K 10-K · filed 2020-03-27 | |
| 2017-12-31 | -$173.18K 10-K · filed 2019-03-22 | |
| 2016-12-31 | $252.66K 10-K · filed 2018-03-29 | |
| 2015-12-31 | $641.73K 10-K · filed 2017-03-30 | |
| 2012-12-31 | $89.79K 10-K · filed 2013-03-28 | |
| 2011-12-31 | -$250.90K 10-K · filed 2013-03-28 | |
| 2010-12-31 | -$262.99K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |